Using this approach, we identified CD45 as a potential B7-H3 interaction partner on Raji B cells and epidermal growth factor receptor (EGFR) as a potential interaction partner on prostate cancer cell line PC3. This evidence concerns the gene CD276 and prostate carcinoma.